(0.47)Diluted net income (loss) per common share $
(0.47)Shares used in computing basic net income (loss) per common share 56,818,88356,039,18656,615,35955,794,357Shares used in computing diluted net income (loss) per common share 57,661,21256,039,18657,316,83055,794,357 DEPOMED, INC.CONDENSED BALANCE SHEETS(in thousands)September 30,December 31,20132012(Unaudited)(1)Cash, cash equivalents and marketable securities
77,892Accounts receivable8,3123,614Receivables from collaborative partners7,76910,078Inventories7,8229,587Property and equipment, net8,3828,237Intangible assets, net32,62625,078Prepaid and other assets6,4717,167Total Assets
141,653Accounts payable and accrued liabilities
32,578Deferred license revenue16,41718,789Other liabilities8,0395,008Contingent consideration liability9,7871,342Shareholders' equity92,21383,936Total liabilities and shareholders' equity
(1) Derived from the audited financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2012.
|SOURCE Depomed, Inc.|
Copyright©2012 PR Newswire.
All rights reserved